| Schedule of Earnings Per Share |
The following table sets forth the computation of
the Company’s basic and diluted net loss per share during the years ended December 31, 2020 and 2019:
| |
|
Year Ended December 31, |
|
| |
|
2020 |
|
|
2019 |
|
| Numerator |
|
|
|
|
|
|
|
|
| Net loss from continuing operations |
|
$ |
(17,643,707 |
) |
|
$ |
(46,582,952 |
) |
| Deemed dividends |
|
|
(263,254,718 |
) |
|
|
(123,861,587 |
) |
| Net loss available to common stockholders, continuing operations |
|
$ |
(280,898,425 |
) |
|
$ |
(170,444,539 |
) |
| Net loss from discontinued operations |
|
|
(696,067 |
) |
|
|
(1,450,869 |
) |
| Net loss available to common stockholders |
|
$ |
(281,594,492 |
) |
|
$ |
(171,895,408 |
) |
| |
|
|
|
|
|
|
|
|
| Denominator |
|
|
|
|
|
|
|
|
| Basic and diluted weighted average common shares outstanding |
|
|
2,987,229 |
|
|
|
558,577 |
|
| |
|
|
|
|
|
|
|
|
| Loss per share, basic and diluted |
|
|
|
|
|
|
|
|
| Basic and diluted, continuing operations |
|
$ |
(94.04 |
) |
|
$ |
(305.14 |
) |
| Basic and diluted, discontinued operations |
|
$ |
(0.23 |
) |
|
$ |
(2.60 |
) |
| Total basic and diluted |
|
$ |
(94.27 |
) |
|
$ |
(307.74 |
) |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
As of December 31, 2020 and 2019, the following potential
common stock equivalents were excluded from the calculation of diluted loss per share as their effect was anti-dilutive:
| |
|
December 31, |
|
| |
|
2020 |
|
|
2019 |
|
| Warrants |
|
|
4,571,165,207 |
|
|
|
63,452,536 |
|
| Convertible preferred stock |
|
|
4,006,169,661 |
|
|
|
7,912,237 |
|
| Convertible debentures |
|
|
327,164,407 |
|
|
|
3,063,478 |
|
| Stock options |
|
|
26 |
|
|
|
30 |
|
| |
|
|
8,904,499,301 |
|
|
|
74,428,281 |
|
|